Aebischer P - Search Results

1

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.

Bobela W, Aebischer P, Schneider BL. Bobela W, et al. Among authors: aebischer p. Biomolecules. 2015 Oct 16;5(4):2675-700. doi: 10.3390/biom5042675. Biomolecules. 2015. PMID: 26501339 Free PMC article. Review.

2

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, Iwatsubo T, Aebischer P. Lo Bianco C, et al. Among authors: aebischer p. Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17510-5. doi: 10.1073/pnas.0405313101. Epub 2004 Dec 2. Proc Natl Acad Sci U S A. 2004. PMID: 15576511 Free PMC article.

3

Viral vectors, animal models and new therapies for Parkinson's disease.

Schneider B, Zufferey R, Aebischer P. Schneider B, et al. Among authors: aebischer p. Parkinsonism Relat Disord. 2008;14 Suppl 2:S169-71. doi: 10.1016/j.parkreldis.2008.04.024. Epub 2008 Jun 27. Parkinsonism Relat Disord. 2008. PMID: 18585946 Review.

4

Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.

Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, Iwatsubo T, Unser M, Aebischer P. Azeredo da Silveira S, et al. Among authors: aebischer p. Hum Mol Genet. 2009 Mar 1;18(5):872-87. doi: 10.1093/hmg/ddn417. Epub 2008 Dec 12. Hum Mol Genet. 2009. PMID: 19074459

5

Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease.

Oueslati A, Paleologou KE, Schneider BL, Aebischer P, Lashuel HA. Oueslati A, et al. Among authors: aebischer p. J Neurosci. 2012 Feb 1;32(5):1536-44. doi: 10.1523/JNEUROSCI.3784-11.2012. J Neurosci. 2012. PMID: 22302797 Free PMC article.

6

Parkinson's disease: gene therapies.

Coune PG, Schneider BL, Aebischer P. Coune PG, et al. Among authors: aebischer p. Cold Spring Harb Perspect Med. 2012 Apr;2(4):a009431. doi: 10.1101/cshperspect.a009431. Cold Spring Harb Perspect Med. 2012. PMID: 22474617 Free PMC article. Review.

7

Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo.

Oueslati A, Schneider BL, Aebischer P, Lashuel HA. Oueslati A, et al. Among authors: aebischer p. Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):E3945-54. doi: 10.1073/pnas.1309991110. Epub 2013 Aug 27. Proc Natl Acad Sci U S A. 2013. PMID: 23983262 Free PMC article.

8

Spinal cord stimulation improves forelimb use in an alpha-synuclein animal model of Parkinson's disease.

Brys I, Bobela W, Schneider BL, Aebischer P, Fuentes R. Brys I, et al. Among authors: aebischer p. Int J Neurosci. 2017 Jan;127(1):28-36. doi: 10.3109/00207454.2016.1138296. Epub 2016 Feb 8. Int J Neurosci. 2017. PMID: 26856727

9

Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity.

Bobela W, Nazeeruddin S, Knott G, Aebischer P, Schneider BL. Bobela W, et al. Among authors: aebischer p. Mol Neurodegener. 2017 Nov 3;12(1):80. doi: 10.1186/s13024-017-0220-x. Mol Neurodegener. 2017. PMID: 29100525 Free PMC article.

10

Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.

Coune PG, Bensadoun JC, Aebischer P, Schneider BL. Coune PG, et al. Among authors: aebischer p. J Parkinsons Dis. 2011;1(4):373-87. doi: 10.3233/JPD-2011-11058. J Parkinsons Dis. 2011. PMID: 23939344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page